drugset / Trial / NCT01516216
Study of Vitamin D in Untreated Metastatic Colorectal Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a prospective, randomized, double-blind phase II trial to evaluate the efficacy and safety of two doses of vitamin D supplementation in combination with standard chemotherapy in participants with previously-untreated metastatic colorectal adenocarcinoma.
Timeline
- Start
- 2012-04-13
- Primary completion
- 2019-11-09
- Completion
- 2019-11-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bevacizumab | Monoclonal antibody | — | Intravenous |
| Comparator | Leucovorin | Small molecule | — | Intravenous |
| Comparator | Oxaliplatin | Small molecule | — | Intravenous |
| Comparator | fluorouracil | Small molecule | — | Intravenous |